194 related articles for article (PubMed ID: 8208618)
1. Effect of abasic linker substitution on triplex formation, Sp1 binding, and specificity in an oligonucleotide targeted to the human Ha-ras promoter.
Mayfield C; Miller D
Nucleic Acids Res; 1994 May; 22(10):1909-16. PubMed ID: 8208618
[TBL] [Abstract][Full Text] [Related]
2. Triplex formation by the human Ha-ras promoter inhibits Sp1 binding and in vitro transcription.
Mayfield C; Ebbinghaus S; Gee J; Jones D; Rodu B; Squibb M; Miller D
J Biol Chem; 1994 Jul; 269(27):18232-8. PubMed ID: 8027084
[TBL] [Abstract][Full Text] [Related]
3. Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with Sp1 and a pyrimidine single strand DNA-binding protein.
Chen S; Supakar PC; Vellanoweth RL; Song CS; Chatterjee B; Roy AK
Mol Endocrinol; 1997 Jan; 11(1):3-15. PubMed ID: 8994183
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides.
Mayfield C; Squibb M; Miller D
Biochemistry; 1994 Mar; 33(11):3358-63. PubMed ID: 8136373
[TBL] [Abstract][Full Text] [Related]
5. Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: effects of the DNA-binding drug chromomycin.
Rutigliano C; Bianchi N; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R
Int J Oncol; 1998 Feb; 12(2):337-43. PubMed ID: 9458359
[TBL] [Abstract][Full Text] [Related]
6. Triplex formation prevents Sp1 binding to the dihydrofolate reductase promoter.
Gee JE; Blume S; Snyder RC; Ray R; Miller DM
J Biol Chem; 1992 Jun; 267(16):11163-7. PubMed ID: 1597451
[TBL] [Abstract][Full Text] [Related]
7. Single strand targeted triplex formation: targeting purine-pyrimidine mixed sequences using abasic linkers.
Kandimalla ER; Manning AN; Venkataraman G; Sasisekharan V; Agrawal S
Nucleic Acids Res; 1995 Nov; 23(21):4510-7. PubMed ID: 7501477
[TBL] [Abstract][Full Text] [Related]
8. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
[TBL] [Abstract][Full Text] [Related]
9. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
10. DNA triple helix formation at target sites containing several pyrimidine interruptions: stabilization by protonated cytosine or 5-(1-propargylamino)dU.
Gowers DM; Bijapur J; Brown T; Fox KR
Biochemistry; 1999 Oct; 38(41):13747-58. PubMed ID: 10521282
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription.
Bianchi N; Rutigliano C; Passadore M; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):919-27. PubMed ID: 9307046
[TBL] [Abstract][Full Text] [Related]
12. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1.
Parks CL; Shenk T
J Biol Chem; 1996 Feb; 271(8):4417-30. PubMed ID: 8626793
[TBL] [Abstract][Full Text] [Related]
13. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
14. Guanine-rich oligonucleotides targeted to a critical R . Y site located in the Ki-ras promoter. The effect of competing self-structures on triplex formation.
Alunni-Fabbroni M; Manzini G; Quadrifoglio F; Xodo LE
Eur J Biochem; 1996 May; 238(1):143-51. PubMed ID: 8665931
[TBL] [Abstract][Full Text] [Related]
15. Triplex formation inhibits HER-2/neu transcription in vitro.
Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
[TBL] [Abstract][Full Text] [Related]
16. Triple helix formation by purine-rich oligonucleotides targeted to the human dihydrofolate reductase promoter.
Blume SW; Gee JE; Shrestha K; Miller DM
Nucleic Acids Res; 1992 Apr; 20(7):1777-84. PubMed ID: 1579471
[TBL] [Abstract][Full Text] [Related]
17. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.
Carbone GM; McGuffie EM; Collier A; Catapano CV
Nucleic Acids Res; 2003 Feb; 31(3):833-43. PubMed ID: 12560478
[TBL] [Abstract][Full Text] [Related]
19. Different contributions of three zinc fingers of transcription factor Sp1 to DNA recognition: novel binding mode of N-terminal finger 1.
Saegusa N; Yokono M; Matsushita K; Sugiura Y
Nucleic Acids Symp Ser; 1997; (37):151-2. PubMed ID: 9586044
[TBL] [Abstract][Full Text] [Related]
20. Functional analyses of natural variation in Sp1 binding sites of a TATA-less promoter.
Segal JA; Barnett JL; Crawford DL
J Mol Evol; 1999 Dec; 49(6):736-49. PubMed ID: 10594175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
